Rebleeding and Mortality After Lower Gastrointestinal Bleeding in Patients Taking Antiplatelets or Anticoagulants

Clinical Gastroenterology and Hepatology

Volumn 17, Issue 7, 2019, Pages 1276-1284.e3

  Oakland, Kathryn ^a,b   Desborough, Michael J ^a,c   Murphy, Mike F ^a   Schachter, Mike ^b   Jairath, Vipul ^d,e  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e University Hospital   (Canada)

Author keywords

Anticoagulant Drugs; Antiplatelet Drugs; Death; Direct Oral Anticoagulants

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FRESH FROZEN PLASMA; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEMATOCRIT; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INTESTINE ISCHEMIA; LABORATORY TEST; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; RECURRENT DISEASE; RETROSPECTIVE STUDY; UNITED KINGDOM; AGED; CLINICAL TRIAL; EPIDEMIOLOGY; FOLLOW UP; HOSPITAL MORTALITY; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RISK FACTOR; SURVIVAL RATE;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED KINGDOM;

EID: 85059597370     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2017.12.032     Document Type: Article

References (20)

1. Lanas, A., Garcia-Rodriguez, L.A., Polo-Tomas, M., et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 104 (2009), 1633–1641.
2. Oakland, K., Guy, R., Uberoi, R., et al. Acute lower GI bleeding in the UK: patient characteristics, interventions and outcomes in the first nationwide audit. Gut, 2017.
3. Hreinsson, J.P., Gumundsson, S., Kalaitzakis, E., et al. Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting. Eur J Gastroenterol Hepatol 25 (2013), 37–43.
4. Pollack, C.V. Jr., Reilly, P.A., Eikelboom, J., et al. Idarucizumab for dabigatran reversal. N Engl J Med 373 (2015), 511–520.
5. Li, C., Hirsh, J., Xie, C., et al. Reversal of the anti-platelet effects of aspirin and clopidogrel. J Thromb Haemost 10 (2012), 521–528.
6. Strate, L.L., Gralnek, I.M., ACG Clinical Guideline: management of patients with acute lower gastrointestinal bleeding. Am J Gastroenterol, 111, 2016, 755.
7. Sung, J.J., Lau, J.Y., Ching, J.Y., et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 152 (2010), 1–9.
8. Oakland, K., Guy, R., Uberoi, R., et al. Study protocol: first nationwide comparative audit of acute lower gastrointestinal bleeding in the UK. BMJ Open, 6, 2016, e011752.
9. Strate, L.L., Orav, E.J., Syngal, S., Early predictors of severity in acute lower intestinal tract bleeding. Arch Intern Med 163 (2003), 838–843.
10. Makris, M., Van Veen, J.J., Tait, C.R., et al. Guideline on the management of bleeding in patients on antithrombotic agents. Br J Haematol 160 (2013), 35–46.
11. Aoki, T., Nagata, N., Niikura, R., et al. Recurrence and mortality among patients hospitalized for acute lower gastrointestinal bleeding. Clin Gastroenterol Hepatol 13 (2015), 488–494.
12. Chan, F.K., Leung Ki, E.L., Wong, G.L., et al. Risks of bleeding recurrence and cardiovascular events with continued aspirin use after lower gastrointestinal hemorrhage. Gastroenterology 151 (2016), 271–277.
13. Devereaux, P.J., Mrkobrada, M., Sessler, D.I., et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 370 (2014), 1494–1503.
14. Keeling, D., Tait, R.C., Watson, H., Peri-operative management of anticoagulation and antiplatelet therapy. Br J Haematol 175 (2016), 602–613.
15. Zakko, L., Rustagi, T., Douglas, M., et al. No benefit from platelet transfusion for gastrointestinal bleeding in patients taking antiplatelet agents. Clin Gastroenterol Hepatol 15 (2016), 46–52.
16. Hreinsson, J.P., Palsdottir, S., Bjornsson, E.S., The association of drugs with severity and specific causes of acute lower gastrointestinal bleeding: a prospective study. J Clin Gastroenterol 50 (2016), 408–413.
17. Nagata, N., Niikura, R., Aoki, T., et al. Risk factors for adverse in-hospital outcomes in acute colonic diverticular hemorrhage. World J Gastroenterol 21 (2015), 10697–10703.
18. Aoki, T., Nagata, N., Shimbo, T., et al. Development and validation of a risk scoring system for severe acute lower gastrointestinal bleeding. Clin Gastroenterol Hepatol 14 (2016), 1562–1570.
19. Qureshi, W., Mittal, C., Patsias, I., et al. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol 113 (2014), 662–668.
20. Sengupta, N., Feuerstein, J.D., Patwardhan, V.R., et al. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. Am J Gastroenterol 110 (2015), 328–335.